Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Respiratory motion during 90Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose.

Ausland L, Revheim ME, Skretting A, Stokke C.

Acta Radiol. 2018 Feb;59(2):132-139. doi: 10.1177/0284185117710052. Epub 2017 May 16.

PMID:
28509566
2.

Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases.

Revheim ME, Haugvik SP, Johnsrud K, Mathisen Ø, Fjeld JG, Skretting A.

Acta Radiol. 2015 Apr;56(4):397-403. doi: 10.1177/0284185114529563. Epub 2014 Mar 28.

PMID:
24682406
3.

Characterization of an asymmetric add-on collimator used with a hand-held gamma probe for radioguided surgery and sentinel node detection: a demonstration of an alternative collimation method.

Johnsrud K, Skretting A, Naum AG, Bogsrud TV, Bach-Gansmo T.

Clin Physiol Funct Imaging. 2013 Nov;33(6):478-82. doi: 10.1111/cpf.12057. Epub 2013 Jun 12.

PMID:
23758686
4.

An implementation of time-efficient respiratory-gated PET acquisition by repeated breath-holds.

Skretting A, Revheim ME, Knudtsen IS, Johnsrud K, Bogsrud TV.

Acta Radiol. 2013 Jul;54(6):672-5. doi: 10.1177/0284185113478007. Epub 2013 Apr 30.

PMID:
23463858
5.

Correction of partial volume effect in (18)F-FDG PET brain studies using coregistered MR volumes: voxel based analysis of tracer uptake in the white matter.

Coello C, Willoch F, Selnes P, Gjerstad L, Fladby T, Skretting A.

Neuroimage. 2013 May 15;72:183-92. doi: 10.1016/j.neuroimage.2013.01.043. Epub 2013 Jan 28.

PMID:
23370062
6.

Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas.

Rusten E, Rødal J, Revheim ME, Skretting A, Bruland OS, Malinen E.

Acta Oncol. 2013 Aug;52(6):1160-7. doi: 10.3109/0284186X.2012.728713. Epub 2012 Dec 3.

PMID:
23198721
7.

A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT.

Skretting A, Evensen JF, Løndalen AM, Bogsrud TV, Glomset OK, Eilertsen K.

Acta Oncol. 2013 Apr;52(3):636-44. doi: 10.3109/0284186X.2012.718095. Epub 2012 Oct 17.

PMID:
23075421
8.

Dynamic FDG PET for assessing early effects of cerebral hypoxia and resuscitation in new-born pigs.

de Lange C, Malinen E, Qu H, Johnsrud K, Skretting A, Saugstad OD, Munkeby BH.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):792-9. doi: 10.1007/s00259-011-2055-y.

PMID:
22297457
9.

Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump.

Djupesland PG, Skretting A.

J Aerosol Med Pulm Drug Deliv. 2012 Oct;25(5):280-9. doi: 10.1089/jamp.2011.0924. Epub 2012 Jan 17.

PMID:
22251061
10.

Dynamic respiratory gated (18)FDG-PET of lung tumors - a feasibility study.

Knudtsen IS, Rødal J, Brustugun OT, Helland Å, Skretting A, Malinen E.

Acta Oncol. 2011 Aug;50(6):889-96. doi: 10.3109/0284186X.2011.583266.

PMID:
21767189
11.

Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT.

Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T.

Mol Imaging Biol. 2011 Dec;13(6):1234-40. doi: 10.1007/s11307-010-0464-0.

12.

Relationship between sharpness and noise in CT images reconstructed with different kernels.

Eldevik K, Nordhøy W, Skretting A.

Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):430-3. doi: 10.1093/rpd/ncq063. Epub 2010 Feb 24.

PMID:
20181647
13.

A phantom for investigation of tumour signal and noise in PET reconstruction with various smoothing filters: experiments and comparisons with simulated intensity diffusion.

Skretting A, Glomset O, Bogsrud TV.

Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):191-4. doi: 10.1093/rpd/ncq051. Epub 2010 Feb 22.

PMID:
20176733
14.

A method for on-site measurements of the effective spatial resolution in PET image volumes reconstructed with OSEM and Gaussian post-filters.

Skretting A.

Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):195-8. doi: 10.1093/rpd/ncq019. Epub 2010 Feb 17.

PMID:
20164108
15.

A new method for scintigraphic quantification of deposition and clearance in anatomical regions of the human nose.

Skretting A, Djupesland PG.

Nucl Med Commun. 2009 Aug;30(8):629-38. doi: 10.1097/MNM.0b013e32832c32b3.

PMID:
19531967
16.

'Intensity diffusion' is a better description than 'partial volume effect'.

Skretting A.

Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):536-7. doi: 10.1007/s00259-008-1032-6. Epub 2009 Jan 21. No abstract available.

PMID:
19156412
17.

A simulation of MRI based dose calculations on the basis of radiotherapy planning CT images.

Eilertsen K, Vestad LN, Geier O, Skretting A.

Acta Oncol. 2008;47(7):1294-302. doi: 10.1080/02841860802256426.

PMID:
18663645
18.

Integrin scintimammography using a dedicated breast imaging, solid-state gamma-camera and (99m)Tc-labelled NC100692.

Bach-Gansmo T, Bogsrud TV, Skretting A.

Clin Physiol Funct Imaging. 2008 Jul;28(4):235-9. doi: 10.1111/j.1475-097X.2008.00801.x. Epub 2008 Jul 1.

PMID:
18384623
20.

Preparation of a radionuclide/gel formulation for localised radiotherapy to a wide range of organs and tissues.

Holte O, Skretting A, Tønnesen HH, Karlsen J.

Pharmazie. 2006 May;61(5):420-4.

PMID:
16724539
21.

Breath actuated device improves delivery to target sites beyond the nasal valve.

Djupesland PG, Skretting A, Winderen M, Holand T.

Laryngoscope. 2006 Mar;116(3):466-72.

PMID:
16540911
22.

Localized internal radiotherapy with 90Y particles embedded in a new thermosetting alginate gel: a feasibility study in pigs.

Holte O, Skretting A, Bach-Gansmo T, Hol PK, Johnsrud K, Tønnesen HH, Karlsen J.

Nucl Med Commun. 2006 Feb;27(2):185-90.

PMID:
16404233
23.

Bi-directional nasal delivery of aerosols can prevent lung deposition.

Djupesland PG, Skretting A, Winderen M, Holand T.

J Aerosol Med. 2004 Fall;17(3):249-59.

PMID:
15625817
24.

Effects of photon attenuation on the determination of cardiac volumes from reconstructed counts in gated blood pool SPET.

Seierstad T, Bogsrud T, Skretting A.

Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):399-402. Epub 2003 Dec 23.

PMID:
14691609
26.

Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts.

Graff BA, Kvinnsland Y, Skretting A, Rofstad EK.

Br J Cancer. 2003 Jan 27;88(2):291-7.

28.
29.

Dose distribution measurements by MRI of a phantom containing lung tissue equivalent compartments made of ferrous sulphate gel.

Olberg S, Skretting A, Bruland O, Olsen DR.

Phys Med Biol. 2000 Oct;45(10):2761-70.

PMID:
11049170
30.
31.

Measurement of the extracellular volume of human melanoma xenografts by contrast enhanced magnetic resonance imaging.

Bjørnaes I, Halsør EF, Skretting A, Rofstad EK.

Magn Reson Imaging. 2000 Jan;18(1):41-8.

PMID:
10642101
32.

Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP).

Aas M, Moe L, Gamlem H, Skretting A, Ottesen N, Bruland OS.

Clin Cancer Res. 1999 Oct;5(10 Suppl):3148s-3152s.

PMID:
10541356
33.

An anthropomorphic phantom for receiver operating characteristic studies in CT imaging of liver lesions.

Olerud HM, Olsen JB, Skretting A.

Br J Radiol. 1999 Jan;72(853):35-43.

PMID:
10341687
34.

[Measurement of glomerular filtration rate in connection with 99Tc-DTPA renography].

Cappelen T, Skretting A, Winderen M, Aas M.

Tidsskr Nor Laegeforen. 1999 Feb 10;119(4):521-5. Norwegian.

PMID:
10081376
35.

Methods for automatic detection of peristaltic waves in the small intestine.

Tennvassås TL, Skretting A.

Eur J Nucl Med. 1998 Nov;25(11):1531-6.

PMID:
9799350
38.

Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging.

Lyng H, Dahle GA, Kaalhus O, Skretting A, Rofstad EK.

Magn Reson Med. 1998 Jul;40(1):89-98.

PMID:
9660558
41.

Determination of 3D dose distribution from intracavitary brachytherapy of cervical cancer by MRI of irradiated ferrous sulphate gel.

Knutsen BH, Skretting A, Hellebust TP, Olsen DR.

Radiother Oncol. 1997 May;43(2):219-27.

PMID:
9192970
42.

Proton relaxation times and interstitial fluid pressure in human melanoma xenografts.

Lyng H, Tufto I, Skretting A, Rofstad EK.

Br J Cancer. 1997;75(2):180-3.

43.

Measurement of dynamic wedge angles and beam profiles by means of MRI ferrous sulphate gel dosimetry.

Bengtsson M, Furre T, Rødal J, Skretting A, Olsen DR.

Phys Med Biol. 1996 Feb;41(2):269-77.

PMID:
8746109
44.

Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach.

Bruland OS, Skretting A, Solheim OP, Aas M.

Acta Oncol. 1996;35(3):381-4.

PMID:
8679270
45.

Methods for fully automated verification of patient set-up in external beam radiotherapy with polygon shaped fields.

Eilertsen K, Skretting A, Tennvassås TL.

Phys Med Biol. 1994 Jun;39(6):993-1012.

PMID:
15551575
46.

Immunoscintigraphy of bone sarcomas--results in 5 patients.

Bruland OS, Fodstad O, Aas M, Solheim OP, Høie J, Skretting A, Winderen M, Michaelsen T, Pihl A.

Eur J Cancer. 1994;30A(10):1484-9.

PMID:
7833107
47.

Attitude of the Norwegian population to drug policy and drug-offences.

Skretting A.

Addiction. 1993 Jan;88(1):125-31.

PMID:
8448503
49.

[Intravenous drug users and the HIV epidemic].

Skretting A.

Tidsskr Nor Laegeforen. 1992 Jun 10;112(15):1981-4. Norwegian.

PMID:
1509465
50.

Blood flow in six human melanoma xenograft lines with different growth characteristics.

Lyng H, Skretting A, Rofstad EK.

Cancer Res. 1992 Feb 1;52(3):584-92.

Supplemental Content

Loading ...
Support Center